非心脏手术围术期心脏事件危险评估与保护性干预

围术期心脏事件是非心脏手术围手术期严重并发症和死亡的重要原因。在临床广泛应用的修订心脏风险指数及ACC／AHA制定的非心脏手术围术期评估指南．可协助临床医生评价非心脏手术心脏风险并做出围术期诊治决策。β受体阻滞剂和他汀类药物可减少高危患者非心脏手术围术期心脏事件及死亡的发生，术前血管重建治疗对于严重冠心病患者是必要和有益的。

Perioperative Cardiac Risk Assessment and Protective Measures in Patients undergoing Noncardiac Surgery

Major cardiac adverse events are important causes of perioperative morbidity and mortality in patients undergoing noncardiac surgery. The ACC/AHA Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery and widely used Revised Cardiac Risk Index are useful in assessing perioperative cardiac risk and can help physicians making diagnosis and treatment decisions. The β-blocker and ststins therapy are both effective measures for reducing pedoperative death and cardiac events during noncardiac surgery in higher-risk patients, Preoperative coronary revascularization is necessary and beneficial for patients with severe coronary heart disease.